A three-dimensional collagen scaffold cell culture system for screening anti-glioma therapeutics

Donglai Lv; Shi-cang Yu; Yi-Fang Ping; Haibo Wu; Xilong Zhao; Huarong Zhang; Youhong Cui; Bing Chen; Xia Zhang; Jianwu Dai; Xiu-Wu Bian; Xiao‐Hong Yao

doi:10.18632/oncotarget.10885

journal article Jul 28, 2016

A three-dimensional collagen scaffold cell culture system for screening anti-glioma therapeutics

Donglai Lv Shi-cang Yu Yi-Fang Ping

Haibo Wu

Xilong Zhao Huarong Zhang Youhong Cui Bing Chen

Xia Zhang

Jianwu Dai

Xiu-Wu Bian

Xiao‐Hong Yao

Oncotarget Vol. 7 No. 35 pp. 56904-56914 · Impact Journals, LLC

View at Publisher Save 10.18632/oncotarget.10885

Topics

No keywords indexed for this article. Browse by subject →

References

50

[1]

Castro "Gene therapy for brain tumors: basic developments and clinical implementation" Neuroscience letters (2012) 10.1016/j.neulet.2012.08.003

[2]

Olson "Exciting New Advances in Neuro-Oncology The Avenue to a Cure for Malignant Glioma" Ca-Cancer J Clin (2010) 10.3322/caac.20069

[3]

Shoemaker "The NCI60 human tumour cell line anticancer drug screen" Nature Reviews Cancer (2006) 10.1038/nrc1951

[4]

Zaman "Bioengineering approaches to study multidrug resistance in tumor cells" Integrative biology: quantitative biosciences from nano to macro (2011) 10.1039/c0ib00142b

[5]

Ernberg "Gene expression perturbation- A growing case for three-dimensional (3D) culture systems" Seminars in Cancer Biology (2005) 10.1016/j.semcancer.2005.06.009

[6]

Abbott "Cell culture: Biology's new dimension" Nature (2003) 10.1038/424870a

[7]

Rich "Potential therapeutic implications of cancer stem cells in glioblastoma" Biochem Pharmacol (2010) 10.1016/j.bcp.2010.04.035

[8]

Panda "Characterization and evaluation of chitosan matrix forgrowth of MCF-7 breast cancer cell lines" Biomaterials (2004) 10.1016/j.biomaterials.2003.12.025

[9]

Yu "Strategies for Isolating and Enriching Cancer Stem Cells: Well Begun Is Half Done" Stem Cells Dev (2013) 10.1089/scd.2012.0613

[10]

Fournier "Prognostic Breast Cancer Signature Identified from 3D Culture Model Accurately Predicts Clinical Outcome across Independent Datasets" Plos One (2008)

[11]

Kaplan "A complex 3D human tissue culture system based on mammary stromal cells and silk scaffolds for modeling breast morphogenesis and function" Biomaterials (2010) 10.1016/j.biomaterials.2010.01.118

[12]

Dai "The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs" Biomaterials (2012) 10.1016/j.biomaterials.2011.10.056

[13]

Ludwig "Modeling Ewing sarcoma tumorswith 3D scaffolds" P Natl Acad Sci USA (2013) 10.1073/pnas.1221403110

[14]

Brain Extracellular Matrix in Neurodegeneration

Dafna Bonneh‐Barkay, Clayton A. Wiley

Brain Pathology 2009 10.1111/j.1750-3639.2008.00195.x

[15]

Zhang "Porous chitosan-hyaluronic acid scaffolds as a mimic of glioblastoma microenvironment ECM" Biomaterials (2013) 10.1016/j.biomaterials.2013.09.034

[16]

Isacke "A role for fibrillar collagen deposition and the collagen internalization receptor endo180 in glioma invasion" Plos One (2010) 10.1371/journal.pone.0009808

[17]

Leitinger "Transmembrane collagen receptors" Annual review of cell and developmental biology (2011) 10.1146/annurev-cellbio-092910-154013

[18]

Chen "Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells" Chin J Cancer (2014) 10.5732/cjc.012.10236

[19]

Winter "Inherent interfacial mechanical gradients in 3D hydrogels influence tumor cell behaviors" Plos One (2012) 10.1371/journal.pone.0035852

[20]

Kumar "Elucidating the mechanobiology of malignant brain tumors using a brain matrix-mimetic hyaluronic acid hydrogel platform" Biomaterials (2011) 10.1016/j.biomaterials.2011.07.005

[21]

MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma

Monika E. Hegi, Annie-Claire Diserens, Thierry Gorlia et al.

New England Journal of Medicine 2005 10.1056/nejmoa043331

[22]

Huang "The pathobiology of collagens in glioma" Molecular cancer research: MCR (2013) 10.1158/1541-7786.mcr-13-0236

[23]

Bengzon "Stem cell-based therapy for malignant glioma" Cancer Treat Rev (2013) 10.1016/j.ctrv.2012.06.006

[24]

Drug penetration in solid tumours

Andrew I. Minchinton, Ian F. Tannock

Nature Reviews Cancer 2006 10.1038/nrc1893

[25]

Yu "Engineering a scaffold-free 3D tumor model fordrug penetration studies" Biomaterials (2010) 10.1016/j.biomaterials.2009.10.049

[26]

Xia "Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition" Oncogene (2011) 10.1038/onc.2011.58

[27]

Miraglia "An RNAi Screen Identifies TRRAP as a Regulator of Brain Tumor-Initiating Cell Differentiation" Cell Stem Cell (2010) 10.1016/j.stem.2009.11.002

[28]

Rich "A three-dimensional organoid culture system derived from human glioblastomas recapitulates the hypoxic gradients and cancer stem cell heterogeneity of tumors found" Cancer Res (2016)

[29]

Banik "Drug Resistance in Glioblastoma: A Mini Review" Neurochemical Research (2012) 10.1007/s11064-011-0701-1

[30]

Miller "Novel approaches to glioma drug design and drug screening" Expert Opin Drug Dis (2013) 10.1517/17460441.2013.807248

[31]

Tang "Characterization of a side population of astrocytoma cells in response to temozolomide" Journal of neurosurgery (2008) 10.3171/jns/2008/109/11/0856

[32]

Nakano "Glioma Stem Cells: Their Role in Chemoresistance" World Neurosurg (2012) 10.1016/j.wneu.2012.01.004

[33]

Kondo "Brain cancer stem-like cells" Eur J Cancer (2006) 10.1016/j.ejca.2006.01.038

[34]

Guo "Isolation and characterization of cancer stem like cells in human glioblastoma cell lines" Cancer Lett (2009) 10.1016/j.canlet.2009.01.016

[35]

Wu "Research progress in cancer stem cells and their drug resistance" Chin J Cancer (2010) 10.5732/cjc.009.10487

[36]

MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma

Monika E. Hegi, Annie-Claire Diserens, Thierry Gorlia et al.

New England Journal of Medicine 2005 10.1056/nejmoa043331

[37]

Buckner "Response to pre-radiation chemotherapy as a predictor of survival in patients with newly diagnosed malignant astrocytoma: A north central cancer treatment group (NCCTG) study" Neuro-Oncology (2004)

[38]

Coons "Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine" Cancer Res (1996)

[39]

Barbieri "The status of the art of human malignant glioma management: the promising role of targeting tumor-initiating cells" Drug Discov Today (2012) 10.1016/j.drudis.2012.06.001

[40]

Shapiro "Intra-arterial cisplatin plus oral etoposide for the treatment of recurrent malignant glioma: a phase II study" Journal of neuro-oncology (2001) 10.1023/a:1006441104260

[41]

Trovo "Reirradiation and lomustine in patients with relapsed high-grade gliomas" International journal of radiation oncology, biology, physics (1999) 10.1016/s0360-3016(98)00457-x

[42]

Levin "Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma" Journal of neuro-oncology (2011) 10.1007/s11060-010-0313-7

[43]

Ng "Temozolomide in the treatment of recurrent malignant glioma in Chinese patients" Hong Kong medical journal (2005)

[44]

Stupp "Recent developments in the use of chemotherapy in brain tumours" Eur J Cancer (2006) 10.1016/j.ejca.2005.06.031

[45]

Inoue "Efficacy of Temozolomide Treatment in Patients with High-grade Glioma" Anticancer Res (2009)

[46]

Bian "Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma" Modern pathology (2007) 10.1038/modpathol.3800942

[47]

Qian "Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2" Oncogene (2015) 10.1038/onc.2014.75

[48]

Darling "Chemosensitivity in childhood brain tumours- evidence of differential sensitivity to lomustine (CCNU) and vincristine" Eur J Cancer (2000)

[49]

Gilsbach "Canchemoresponse assays help find new treatment regimens for malignant gliomas?" Anti-Cancer Drug (2014) 10.1097/cad.0000000000000062

[50]

Tanaka "Collagen gel matrix assay as anchemosensitivity test for malignant astrocytic tumors" Int J Clin Oncol (2007) 10.1007/s10147-006-0636-8

Metrics

81

Citations

50

References

Details

Published: Jul 28, 2016
Vol/Issue: 7(35)
Pages: 56904-56914

Authors

D

Donglai Lv